Behaviour disorders in brain-damaged children.
D000293:Adolescent; D000367:Age Factors; D000661:Amphetamine / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D001925:Brain Damage, Chronic / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D001930:Brain Injuries / Q000150:complications; D002648:Child; D002653:Child Behavior Disorders / Q000209:etiology*; D002675:Child, Preschool; D004519:Education, Special; D004569:Electroencephalography; D004827:Epilepsy / Q000150:complications / Q000209:etiology; D006801:Humans; D006948:Hyperkinesis / Q000150:complications / Q000209:etiology; D007231:Infant, Newborn; D007859:Learning Disabilities / Q000209:etiology; D001523:Mental Disorders / Q000139:chemically induced / Q000209:etiology; D010551:Personality; D011011:Pneumoencephalography; D011581:Psychological Tests; D011599:Psychopathology; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000927:Anticonvulsants; D014149:Tranquilizing Agents; D000661:Amphetamine